Cannabis in Germany
Mixed / PartialOverview
Germany implemented partial cannabis legalization on April 1, 2024, through the Cannabis Act (Cannabisgesetz or CanG), making it the largest European country to legalize recreational cannabis use. The law permits adults to possess up to 25 grams of cannabis in public and cultivate up to three plants at home. Non-commercial cannabis social clubs (Anbauvereinigungen) with a maximum of 500 members each can collectively grow and distribute cannabis to their members.
Germany's medical cannabis program, established in 2017, has been one of Europe's most significant. Physicians can prescribe cannabis for any condition where they deem it appropriate, and health insurance companies may cover the cost. The medical market has grown substantially, with Germany importing large quantities of medical cannabis from Canada, Portugal, the Netherlands, and other licensed producers.
The 2024 recreational legalization law explicitly did not create a commercial retail market. Instead, it established a framework for personal cultivation and social clubs, with a second phase contemplating regional pilot programs for commercial sales that have yet to be implemented. This approach means Germany has legalized possession and personal cultivation but does not yet have dispensaries or commercial retail sales.
Despite the limited commercial framework, Germany's legalization has been transformative for the European cannabis landscape. As the EU's largest economy with 84 million people, Germany's policy shift has influenced discussions in other European nations and increased demand for legally produced cannabis. The medical market alone was valued at approximately $1.2 billion by 2025 and continues to grow as patient access improves and social stigma decreases.
Key Facts
- Partial recreational legalization effective April 1, 2024
- Adults may possess up to 25g in public and grow 3 plants at home
- Cannabis social clubs of up to 500 members permitted for collective growing
- Medical cannabis legal since 2017 with insurance coverage possible
- No commercial recreational retail sales framework yet implemented
- Largest economy in Europe to legalize any form of recreational cannabis
- Major importer of medical cannabis from Canada and other countries
Recent Developments
Cannabis social clubs beginning to operate across major German cities
Regional pilot programs for commercial retail sales under discussion
Medical cannabis patient numbers continue to grow significantly
Political debates ongoing about expanding to full commercial model
Investment Implications
Germany represents the single most important European cannabis market due to its population, economic size, and growing medical program. Companies exporting medical cannabis to Germany — particularly Canadian LPs like Tilray, Aurora, and Canopy Growth — benefit from the growing patient base. The potential introduction of commercial recreational retail would be a major catalyst. Investors should also watch German-listed cannabis companies and EU-focused operators positioning for broader European legalization.